Tonix Pharmaceuticals Holding Corp.

TNXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.59

-$0.13 (-1.21%)

At close: Sep 22, 2026, 4:00 PM ET

$10.78

+$0.19 (+1.79%)

After-hours: Sep 22, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.21%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $168.81M

1D Range

10.48 11.17

52W Range

9.40 27.27

Valuation (TTM)

PE -0.81

PB 0.77

EV/EBITDA 0.03

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target $27

Cash Flow

FCF Yield -92.5%

SBC Adj. FCF Yield -97.1%

SBC Impact -5.0%

Margins

Gross Margin 80.3%

Operating Margin -568.4%

FCF Margin -543.3%

Growth (CAGR)

Revenue 3Y | 5Y 48.6% | 66.2%

Dil EPS 3Y | 5Y 149.3% | 78.9%

FCF 3Y | 5Y -41.1% | 4.2%

Returns

ROA -62.8%

ROE -69.0%

ROIC -74.0%

Financial Health

Net Cash

$176.23M

Current Ratio 6.61

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and com...

Sector Healthcare

Industry Biotechnology

Employees 142

IPO Date May 9, 2012

Website www.tonixpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞